PPARG and early-onset autosomal dominant Alzheimer disease: The neuroprotective role of PPAR-γ agonists has been previously observed in models of central nervous system diseases, including acute cerebral ischemia, Parkinson’s disease and Alzheimer’s disease (53–55).